An AI-powered ECG device can detect previous silent heart attacks using a small electronic pad connected to a mobile phone.
The device screens for undiagnosed chronic conditions like valvular heart disease, rheumatic heart disease, and different kinds of heart failure.
A trial of this device was conducted in Tamil Nadu by Dr. Ziad Obermeyer and his team from UC Berkeley.
The device can rule out these conditions in 90-95% of people, with a confirmatory ultrasound needed for the remaining 5%.
Detailed Insights:
The AI-ECG technology aims to identify individuals who have experienced silent heart attacks to enable timely medical intervention and prevent future occurrences.
The device uses a one-lead ECG, and while it may not replace confirmatory tests, it significantly reduces the need for them.
The data collected is carefully de-identified and can be shared with researchers for building non-profit tools, ensuring public sector involvement.
Besides detecting past heart attacks, similar tools can be developed for metabolic illnesses like diabetes, heart disease, and chronic kidney failure.
India is a favorable location for such projects due to the availability of large volumes of data, cost-effectiveness, abundant human capital, and infrastructure for rigorous evaluation.
Key Concepts Involved:
Electrocardiogram (ECG): A test that records the electrical activity of the heart over a period of time using electrodes placed on the skin.
Silent Heart Attack: A heart attack that occurs without the typical symptoms such as chest pain, shortness of breath, and sweating.
Valvular Heart Disease: A condition in which one or more of the heart valves do not work properly.